Bipolar disorder is also known as manic depression. It is a mental illness that brings severe high and low moods and unusual shifts in sleep, energy, thinking, and behavior. People having bipolar disorder experience the feeling. On one hand, they are overly happy and energized and on the other offhand, they end up feeling very sad, hopeless, and sluggish. One can think of the highs and the lows as two “poles” of mood, which is why it is termed as “bipolar” disorder. There are three broad types of Bipolar Disorder: Bipolar I Disorder (mania or a mixed episode) – This is a classic manic-depressive form of the illness characterized by at least one manic episode or mixed episode. Usually but not always, bipolar disorder I also involves at least one episode of depression; Bipolar II Disorder (hypomania and depression) – The person suffering from bipolar II disorder does not experience complete manic episodes. Instead it involves the episodes of hypomania and severe depression; Cyclothymia (hypomania and mild depression) – This is a milder form of bipolar disorder that consists of cyclical mood swings. However, the symptoms are less severe than full-blown mania or depression.
Access research report on global bipolar disorder market: http://www.grandviewresearch.com/industry-analysis/bipolar-disorder-market
America conquered the bipolar disorder therapeutics market in 2014 with a remarkable share of around 65%; followed by the EMEA and the Asia Pacific region. Globally, bipolar disorder market is segmented on the basis of drug class, mechanism of action, and geography. On the basis of drug class the market is segmented into Mood stabilizers, Anticonvulsants, Atypical antipsychotics, Antidepressant drugs, and Anti-anxiety drugs. For reducing manic symptoms in bipolar disorder, mood stabilizers are the drugs that are highly suggested and used as these drugs help in soothing the symptoms observed in the individuals and also help in treating the suicidal tendencies; i.e. they balance certain brain chemicals (neurotransmitters) that control emotional states and behavior (lithium, valproic acid, and carbamazepine).
Related reports by Grand View Research:
Anticonvulsants are used to control or prevent seizures or stop an ongoing series of seizures such as to treat epilepsy, prevent migraines, and the other brain disorders. Anticonvulsants such as Depakote, Depakene, Lamictal, and Tegretol are the medicines that differ in the types of bipolar symptoms that get treated. SSRIs, SNRIs, TCAs, etc. are the antidepressant drugs used. Benzodiazepines are a class of drugs often used to treat anxiety in patients with co-occurring bipolar disorder. However, they may cause side-effects, including physical dependence and tolerance. On the basis of mechanism of action, bipolar disorder therapeutics market is segmented as Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta blockers, and others.
Read Our Blogs – grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
For More Information: www.grandviewresearch.com